MedMira (MedMira) COGS-to-Revenue : 0.54 (As of Jan. 2024)

View and export this data going back to . Start your Free Trial

What is MedMira COGS-to-Revenue?

MedMira's Cost of Goods Sold for the three months ended in Jan. 2024 was $0.06 Mil. Its Revenue for the three months ended in Jan. 2024 was $0.11 Mil.

MedMira's COGS to Revenue for the three months ended in Jan. 2024 was 0.54.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. MedMira's Gross Margin % for the three months ended in Jan. 2024 was 45.95%.

MedMira COGS-to-Revenue Historical Data

The historical data trend for MedMira's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira COGS-to-Revenue Chart

MedMira Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

COGS-to-Revenue

Get a 7-Day Free Trial

0.20

0.38

0.20

0.68

0.31

MedMira Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
COGS-to-Revenue	Get a 7-Day Free Trial															0.47	0.43	-0.50	0.40	0.54

MedMira COGS-to-Revenue Calculation

MedMira's COGS to Revenue for the fiscal year that ended in Jul. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.101	/	0.328
	=	0.31

MedMira's COGS to Revenue for the quarter that ended in Jan. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.06	/	0.111
	=	0.54

MedMira (OTCPK:MMIRF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

MedMira's Gross Margin % for the three months ended in Jan. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.06 / 0.111
	=	45.95 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

MedMira COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of MedMira's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMira (MedMira) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (OTCPK:MMIRF) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

47M:Germany MIR:Canada

Address

155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3

Website

https://www.medmira.com

MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.